Page 23 - Latest Updates on Trump tariffs

India manufacturing PMI eases to 57.7 in Sep, selling prices hit 12-yr high

The September manufacturing PMI reading marked the weakest improvement in sector health since May, though it remained well above the neutral 50 threshold

Others exploited US for years, tariffs now ensure fair treatment: Trump

"I love tariffs. Most beautiful word... Tariff is my favourite word... We're becoming rich as hell...," said US President Donald Trump

Trump sets new tariffs on lumber, wood products in bid to boost US industry

Trump said the planned actions will 'strengthen supply chains, bolster industrial resilience, create high-quality jobs and increase domestic capacity utilization for wood products'

Stock Market Close: Sensex dips 97 pts, logs 8th straight loss ahead of RBI policy; Nifty at 24,611

Sensex Today| Stock Market Close Highlights today, Sep 30: In the broader market, Nifty MidCap 100 index closed lower by 0.01 per cent, while NIfty SmallCap was up 0.08 per cent.

Foreign investors exit Indian stocks at record pace amid tariff woes

Overseas investors have pulled a net $16.8 billion from local shares this year through Sept. 26, nearing the record set in 2022

Indian economy to grow at 6.5% in FY26, US tariffs to weigh on exports: ADB

Despite a strong 7.8 per cent growth in the first quarter, the Indian economy is expected to grow at 6.5 per cent in the current financial year as the impact of US tariffs on Indian exports will reduce prospects, particularly in the second half, ADB said on Tuesday. It is to be noted that the Asian Development Outlook (ADO) of the Asian Development Bank (ADB), released in April, had projected a higher growth rate of 7 per cent, which was lowered to 6.5 per cent in the July report on concern of a steep 50 per cent US tariffs on shipment from India. While GDP grew strongly in the first quarter (Q1) of FY26 at 7.8 per cent on improved consumption and government spending, additional US tariffs on Indian exports will reduce growth, particularly in the second half of FY26 and in FY27, though resilient domestic demand and service exports will cushion the impact, ADO September 2025 said. The reduction in exports will impact India's GDP in both FY26 and FY27 as the tariffs are implemented. A

US President Donald Trump announces 100% levies on foreign-made films

US tariffs may script huge setback for Indian films; industry's revenue from US may take 30-40% hit

Stock Market Close Highlights: Sensex, Nifty flat; oil & gas, PSB stocks gain

Stock Market Close Highlights, Sep 29: In the broader market, Nifty MidCap 100 index ended 0.27 per cent higher, while Nifty SmallCap 100 index slipped 0.07 per cent

Chinese firms' low profit margins face new risks from Trump tariffs

The net profit margins of US listed companies in tradeable goods averaged around 12 per cent last year, more than double the 4.9 per cent of their Chinese peers

Tariff uncertainties may spur rise in third-party pharma manufacturing

Analysts say Indian drugmakers may lean on CDMOs, US plants and diversification to safeguard high-value products as Trump's 100% tariff threat looms over patented drugs

Best of BS Opinion: GST 2.0 reforms miss underlying core principles

Today's pieces look at the available space for more rate cuts, the sorry state of tribunals, why GST reforms are not really that, and how India can harness its vast non-export MSME sector

Beyond the tariff tears: The 99 per cent opportunity in India's MSME engine

The number of exporting MSMEs, despite a commendable trebling in the last four years, was a meagre 173,350 in May last year

US commerce secy calls for India to open mkts, stop actions harming America

Lutnick said that India must open its markets and take actions that would not 'harm' the US

Sun Pharma hit by US tariff risk, but earnings impact to remain limited

The imposition of a 100 per cent tariff by the US on imports of branded and patented pharmaceutical products starting October 1 may not significantly hurt Indian drug makers, with Sun Pharma being exposed to some headline risk but with limited earnings impact, according to analysts. Among Indian companies, only Sun Pharma has sizeable sales from patented drugs in the US (about 17 per cent of 2024-25 revenue), HSBC Global Investment Research said in a report. The US last week announced the imposition of a 100 per cent tariff on branded or patented drugs entering the United States from October 1, except for pharmaceutical companies building manufacturing plants in the US. The exemption covers projects where construction has started, including sites that have broken ground or are under construction. HSBC said Sun Pharma reported global sales of USD 1.217 billion from patented products in FY25, of which the US market accounted for about USD 1.1 billion (85-90 per cent of global sales),

India a country US 'needs to fix': Trump aide Lutnick amid tariff row

US Commerce Secretary Howard Lutnick escalated criticism of India, urging New Delhi to lower tariffs and rethink Russian oil imports as trade tensions with Washington mount

US tariffs on Indian goods pose major growth risks: Crisil Intelligence

High tariffs imposed by the United States on Indian goods pose a major risk to the country's growth, Crisil Intelligence said in its September report. The tariffs will impact both Indian goods exports and investments, the report added. However, domestic consumption, driven by benign inflation and rate cuts, is expected to support growth, it said. The country's GDP rose to a five-quarter high of 7.8 per cent in the first quarter of fiscal 2025-26, up from 7.4 per cent in the similar quarter in the previous year. Nominal GDP growth, however, slowed to 8.8 per cent from 10.8 per cent during the same period, it added. The report said consumer price index (CPI) inflation is likely to soften to 3.5 per cent in the current fiscal from 4.6 per cent in the previous year. Healthy agricultural growth is expected to keep food inflation under check, though the impact of excess rain was yet to be fully assessed. Lower crude prices and benign global commodity prices are expected to contain non

Brics must defend multilateral trading amid tariff volatility: Jaishankar

External Affairs Minister S Jaishankar has called on BRICS to defend the multilateral trading system amid increasing protectionism and tariff volatility during a meeting of the bloc's foreign ministers here on the sidelines of the UN General Assembly session. When multilateralism is under stress, BRICS has stood firm as a strong voice of reason and constructive change, Jaishankar said in a social media post. In a turbulent world, BRICS must reinforce the message of peacebuilding, dialogue, diplomacy and adherence to international law, he said. As rising protectionism, tariff volatility and non-tariff barriers impact trade flows, BRICS must defend the multilateral trading system, he said. Jaishankar's remarks come weeks after the US slapped 50 per cent tariffs on India, including an additional 25 per cent penalty for its purchase of Russian oil, among the highest in the world. The external affairs minister also called on the bloc to amplify its collective call for a comprehensive .

India may import US corn for ethanol production as trade talks advance

New Delhi seeks removal of penal tariffs on Russian oil purchases as Washington pushes soybean and corn sales, with both sides aiming to seal a trade pact by fall

Indian pharma firms likely to dodge immediate impact of Trump's tariff

Trump's 100% tariffs on branded drugs will spare Indian generics, though analysts see exposure for Sun Pharma, Biocon and Aurobindo, with Jubilant Pharmova set to benefit

Reforms to boost growth, but tariff suspense a risk, says FinMin

Finance ministry warns tariff risks could hit jobs and consumption, while GST rationalisation and reforms are seen as key to sustaining India's growth amid global uncertainties